Hyperoside has demonstrated its efficacy in inhibiting the hypoxia-induced proliferation of cancer cells by enhancing ferrous accumulation in the adenosine monophosphate-activated protein kinase (AMPK)/heme oxygenase-1 (HO-1) axis (Chen et al., 2020). Here, HMOX1 is linked to cancer.